Detalhe da pesquisa
1.
Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.
Value Health
; 18(6): 800-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409607
2.
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection.
Emerg Microbes Infect
; 9(1): 928-939, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32312174